Emerging treatment options for nasopharyngeal carcinoma

References

• Wee JT Ha TC Loong SL Qian CN Is nasopharyngeal cancer really a “Cantonese cancer”? Chin J Cancer 2010 29 5 517 526 20426903
   PubMedGoogle Scholar
• Lee AW Ng WT Chan YH Sze H Chan C Lam TH The battle against nasopharyngeal cancer Radiother Oncol 2012 104 3 272 278 22938727
   PubMed Web of Science ®Google Scholar
• Wang TJC Riaz N Cheng SK Lu JJ Lee NY Intensity-modulated radiation therapy for nasopharyngeal carcinoma: a review J Radiat Oncol 2012 1 2 129 146
   Google Scholar
• Lee AW Lin JC Ng WT Current management of nasopharyngeal cancer Semin Radiat Oncol 2012 22 3 233 244 22687948
   PubMed Web of Science ®Google Scholar
• Ma BB Hui EP Chan AT Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions Cancer Sci 2008 99 7 1311 1318 18498420
   PubMed Web of Science ®Google Scholar
• Heng DM Wee J Fong KW Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma Cancer 1999 86 10 1912 1920 10570413
   PubMed Web of Science ®Google Scholar
• Ma J Mai HQ Hong MH Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations? Int J Radiat Oncol Biol Phys 2001 50 5 1181 1189 11483327
   PubMed Web of Science ®Google Scholar
• Yeh SA Tang Y Lui CC Huang YJ Huang EY Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone Int J Radiat Oncol Biol Phys 2005 62 3 672 679 15936544
   PubMed Web of Science ®Google Scholar
• Au JS Law CK Foo W Lau WH In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: prognostic homogeneity and proposed refinements Int J Radiat Oncol Biol Phys 2003 56 2 413 426 12738316
   PubMed Web of Science ®Google Scholar
• Chua DT Sham JS Wei WI Ho WK Au GK The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma Cancer 2001 92 11 2845 2855 11753958
   PubMed Web of Science ®Google Scholar
• Leung TW Tung SY Sze WK Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns Head Neck 2005 27 7 555 565 15880410
   PubMed Web of Science ®Google Scholar
• Lee AW Sze WM Au JS Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 2005 61 4 1107 1116 15752890
   PubMed Web of Science ®Google Scholar
• Lai SZ Li WF Chen L How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 2011 80 3 661 668 20643517
   PubMed Web of Science ®Google Scholar
• Sobin L Gospodarowicz M Wittekind C TNM Classification of Malignant Tumours 7th ed Oxford Wiley-Blackwell 2009
   Google Scholar
• Yu E O’Sullivan B Kim J Siu L Bartlett E Magnetic resonance imaging of nasopharyngeal carcinoma Expert Rev Anticancer Ther 2010 10 3 365 375 20214518
   PubMed Web of Science ®Google Scholar
• Chan AT Grégoire V Lefebvre JL Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2012 23 Suppl 7 vii83 85 22997460
   PubMed Web of Science ®Google Scholar
• Liu FY Lin CY Chang JT 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma J Nucl Med 2007 48 10 1614 1619 17873135
   PubMed Web of Science ®Google Scholar
• Chang MC Chen JH Liang JA Yang KT Cheng KY Kao CH Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis Eur J Radiol 2012 82 2 366 373 23083522
   PubMed Web of Science ®Google Scholar
• Greene FL Page DL Fleming ID AJCC Cancer Staging Manual 6th ed Philadelphia Lippincott Raven 2002
   Google Scholar
• Chen L Mao YP Xie FY The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China Radiother Oncol 2012 104 3 331 337 22103978
   PubMed Web of Science ®Google Scholar
• Lee AW Ng WT Chan LK The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement Oral Oncol 2012 48 10 1007 1013 22525607
   PubMed Web of Science ®Google Scholar
• Sze WM Lee AW Yau TK Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control Int J Radiat Oncol Biol Phys 2004 59 1 21 27 15093895
   PubMed Web of Science ®Google Scholar
• Chang CC Chen MK Liu MT Wu HK The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors Head Neck 2002 24 10 940 946 12369073
   PubMed Web of Science ®Google Scholar
• Guo R Sun Y Yu XL Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? Radiother Oncol 2012 104 3 294 299 22998947
   PubMed Web of Science ®Google Scholar
• Wu Z Zeng RF Su Y Gu MF Huang SM Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy Head Neck Epub June 19, 2012
   Web of Science ®Google Scholar
• Lee JT Ko CY Has survival improved for nasopharyngeal carcinoma in the United States? Otolaryngol Head Neck Surg 2005 132 2 303 308 15692545
   PubMed Web of Science ®Google Scholar
• Leung SF Zee B Ma BB Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma J Clin Oncol 2006 24 34 5414 5418 17135642
   PubMed Web of Science ®Google Scholar
• Leung SF Chan ATC Zee B Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type Cancer 2003 98 2 288 291 12872347
   PubMed Web of Science ®Google Scholar
• Chan AT Lo YM Zee B Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma J Natl Cancer Inst 2002 94 21 1614 1619 12419787
   PubMedGoogle Scholar
• Lin JC Wang WY Chen KY Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl J Med 2004 350 24 2461 2470 15190138
   PubMed Web of Science ®Google Scholar
• Chan SL Hui EP Leung SF Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma BMC Cancer 2006 6 259 17076893
   PubMed Web of Science ®Google Scholar
• Felip E Rosell R Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response Exp Rev Mol Diagn 2007 7 3 261 268
   PubMed Web of Science ®Google Scholar
• Sun JM Ahn MJ Park MJ Expression of excision repair cross-complementation group 1 as predictive marker for nasopharyngeal cancer treated with concurrent chemoradiotherapy Int J Radiat Oncol Biol Phys 2011 80 3 655 660 21621119
   PubMed Web of Science ®Google Scholar
• Chan SH Cheung FM Ng WT Can the analysis of ERCC1 expression contribute to individualized therapy in nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 2011 79 5 1414 1420 20605357
   PubMed Web of Science ®Google Scholar
• Huang PY Li Y Mai HQ Expression of ERCC1 predicts clinical outcome in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy Oral Oncol 2012 48 10 964 968 22571922
   PubMed Web of Science ®Google Scholar
• Veldeman L Madani I Hulstaert F De Meerleer G Mareel M De Neve W Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies Lancet Oncol 2008 9 4 367 375 18374290
   PubMed Web of Science ®Google Scholar
• Lee N Xia P Quivey JM Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 2002 53 1 12 22 12007936
   PubMed Web of Science ®Google Scholar
• Kam MK Teo PM Chau RM Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience Int J Radiat Oncol Biol Phys 2004 60 5 1440 1450 15590175
   PubMed Web of Science ®Google Scholar
• Wolden SL Chen WC Pfster DG Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan–Kettering experience Int J Radiat Oncol Biol Phys 2006 64 1 57 62 15936155
   PubMed Web of Science ®Google Scholar
• Kwong DL Sham JS Leung LH Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 2006 64 2 374 381 16213105
   PubMed Web of Science ®Google Scholar
• Bakst RL Lee N Pfister DG Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial Int J Radiat Oncol Biol Phys 2011 80 1 148 153 20605352
   PubMed Web of Science ®Google Scholar
• Ma BB Kam MK Leung SF A phase II study of concurrrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma Ann Oncol 2012 23 5 1287 1292 21948811
   PubMed Web of Science ®Google Scholar
• Tham IW Hee SW Yeo RM Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy – the National Cancer Centre Singapore Experience Int J Radiat Oncol Biol Phys 2009 75 5 1481 1486 19386431
   PubMed Web of Science ®Google Scholar
• Lin S Pan J Han L Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series Int J Radiat Oncol Biol Phys 2009 75 4 1071 1078 19362784
   PubMed Web of Science ®Google Scholar
• Lee N Harris J Garden AS Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 J Clin Oncol 2009 27 22 3684 3690 19564532
   PubMed Web of Science ®Google Scholar
• Wong FC Ng AW Lee VH Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 2010 76 1 138 145 19646824
   PubMed Web of Science ®Google Scholar
• Ng WT Lee MC Hung WM Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 2011 79 2 420 428 20452132
   PubMed Web of Science ®Google Scholar
• Xiao WW Huang SM Han F Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study Cancer 2011 117 9 1874 1883 21509764
   PubMed Web of Science ®Google Scholar
• Su SF Han F Zhao C Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone Int J Radiat Oncol Biol Phys 2012 82 1 327 333 21035959
   PubMed Web of Science ®Google Scholar
• Lee N Zhang Q Kim J Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial Lancet Oncol 2012 13 2 172 180 22178121
   PubMed Web of Science ®Google Scholar
• Tham IW Lu JJ Controversies and challenges in the current management of nasopharyngeal cancer Expert Rev Anticancer Ther 2010 10 9 1439 1450 20836679
   PubMed Web of Science ®Google Scholar
• Qin DX Hu YH Yan JH Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation Cancer 1988 61 6 1117 1124 3342372
   PubMed Web of Science ®Google Scholar
• Tang LL Mao Y Liu L The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging Cancer 2009 115 3 680 688 19117352
   PubMed Web of Science ®Google Scholar
• Gao Y Zhu G Lu J Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 2010 77 5 1397 1402 20044215
   PubMed Web of Science ®Google Scholar
• Ou X Shen C Kong L Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation Oral Oncol 2012 48 10 1045 1050 22633108
   PubMed Web of Science ®Google Scholar
• Chen JZ Le QT Han F Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and V(b) in patients with N(0-1) nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys Epub September 10, 2012
   Web of Science ®Google Scholar
• Pow EH Kwong DL McMillan AS Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial Int Radiat Oncol Biol Phys 2006 66 4 981 991
   PubMed Web of Science ®Google Scholar
• Kam MK Leung SF Zee B Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients J Clin Oncol 2007 25 31 4873 4879 17971582
   PubMed Web of Science ®Google Scholar
• Fang FM Tsai WL Lee TF Liao KC Chen HC Hsu HC Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment Radiother Oncol 2010 97 2 263 269 20817290
   PubMed Web of Science ®Google Scholar
• Wang SZ Li J Miyamoto CT A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique Radiother Oncol 2009 93 3 530 533 19853315
   PubMed Web of Science ®Google Scholar
• Pan CC Eisbruch A Lee JS Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients Int J Radiat Oncol Biol Phys 2005 61 5 1393 1402 15817342
   PubMed Web of Science ®Google Scholar
• Lee AW Ng WT Hung WM Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient-and-treatment-related risk factors Int J Radiat Oncol Biol Phys 2009 73 4 1121 1128 18723296
   PubMed Web of Science ®Google Scholar
• Tuan JK Ha TC Ong WS Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma Radiother Oncol 2012 104 3 305 311 22280806
   PubMed Web of Science ®Google Scholar
• Lee AW Chan DK Fowler JF Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma Radiother Oncol 1995 36 1 24 31 8525022
   PubMed Web of Science ®Google Scholar
• Lee AW Kwong DL Leung SF Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time Int J Radiat Oncol Biol Phys 2002 53 1 75 85 12007944
   PubMed Web of Science ®Google Scholar
• Rison RA Beydoun SR Delayed cervicobulbar neuronopathy and myokymia after head and neck radiotherapy for nasopharyngeal carcinoma: a case report J Clin Neuromuscul Dis 2011 12 3 147 152 21321494
   PubMedGoogle Scholar
• Chua DT Sham JS Kwong DL Au GK Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma Cancer 2003 98 1 74 80 12833458
   PubMed Web of Science ®Google Scholar
• Xiao WW Han F Lu TX Chen CY Huang Y Zhao C Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 2009 74 4 1070 1076 19231110
   PubMed Web of Science ®Google Scholar
• Leung SF Chan AT Zee B Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type Cancer 2003 98 2 288 291 12872347
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M LeBlanc M Giri PG Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 1998 16 4 1310 1317 9552031
   PubMed Web of Science ®Google Scholar
• Sun Y Tang LL Chen L Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system BMC Cancer 2012 12 68 22336097
   PubMed Web of Science ®Google Scholar
• Chua DT Ma J Sham JS Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: subgroup analysis of two phase III trials Int J Radiat Oncol Biol Phys 2006 65 5 1300 1306 16750333
   PubMed Web of Science ®Google Scholar
• Lin JC Liang WM Jan JS Jiang RS Lin AC Another way to estimate outcome of advanced nasopharyngeal carcinoma – is concurrent chemoradiotherapy adequate? Int J Radiat Oncol Biol Phys 2004 60 1 156 164 15337551
   PubMed Web of Science ®Google Scholar
• Cheng SH Tsai SY Yen KL Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma J Clin Oncol 2000 18 10 2040 2045 10811668
   PubMed Web of Science ®Google Scholar
• Chen QY Wen YF Guo L Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase iii randomized trial J Natl Cancer Inst 2011 103 23 1761 1770 22056739
   PubMed Web of Science ®Google Scholar
• Wee J Tan EH Tai BC Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 2005 23 27 6730 6738 16170180
   PubMed Web of Science ®Google Scholar
• Lee AW Tung SY Chua DT Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 2010 102 15 1188 1198 20634482
   PubMed Web of Science ®Google Scholar
• Chen Y Liu MZ Liang SB Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China Int J Radiat Oncol Biol Phys 2008 71 5 1356 1364 18472356
   PubMed Web of Science ®Google Scholar
• Lee AW Tung SY Chan AT A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma Radiother Oncol 2011 98 1 15 22 20971520
   PubMed Web of Science ®Google Scholar
• Lin JC Jan JS Hsu CY Liang WM Jiang RS Wang WY Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 2003 21 4 631 637 12586799
   PubMed Web of Science ®Google Scholar
• Chan AT Ngan RK Teo PM Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 2005 97 7 536 539 15812080
   PubMed Web of Science ®Google Scholar
• Zhang L Zhao C Peng PJ Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results J Clin Oncol 2005 23 33 8461 8468 16230677
   PubMed Web of Science ®Google Scholar
• Kwong DL Sham JS Au GK Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study J Clin Oncol 2004 22 13 2643 2653 15226332
   PubMed Web of Science ®Google Scholar
• Chitapanarux I Lorvidhaya V Kamnerdsupaphon P Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial Eur J Cancer 2007 43 9 1399 1406 17467265
   PubMed Web of Science ®Google Scholar
• Yau TK Lee AW Wong DH Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes Int J Radiat Oncol Biol Phys 2006 66 4 1004 1010 17145529
   PubMed Web of Science ®Google Scholar
• Chua DT Sham JS Choy D Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group Cancer 1998 83 11 2270 2283 9840526
   PubMed Web of Science ®Google Scholar
• Hareyama M Sakata K Shirato H A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma Cancer 2002 94 8 2217 2223 12001120
   PubMed Web of Science ®Google Scholar
• Ma J Mai HQ Hong MH Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 2001 19 5 1350 1357 11230478
   PubMed Web of Science ®Google Scholar
• Roussy IG Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA I trial Int J Radiat Oncol Biol Phys 1996 35 3 463 469 8655368
   PubMed Web of Science ®Google Scholar
• Rossi A Molinari R Boracchi P Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study J Clin Oncol 1988 6 9 1401 1410 3047335
   PubMed Web of Science ®Google Scholar
• Chan AT Teo PM Leung TW A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 1995 33 3 569 577 7558945
   PubMed Web of Science ®Google Scholar
• Baujat B Audry H Bourhis J Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 2006 64 1 47 56 16377415
   PubMed Web of Science ®Google Scholar
• Zhang L Zhao C Ghimire B The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials BMC Cancer 2010 10 558 20950416
   PubMed Web of Science ®Google Scholar
• Chen L Hu CS Chen XZ Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial Lancet Oncol 2012 13 2 163 171 22154591
   PubMed Web of Science ®Google Scholar
• Lee AW Tung SY Ngan RK Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials Eur J Cancer 2011 47 5 656 666 21112774
   PubMed Web of Science ®Google Scholar
• Köhne CH Peters GJ UFT: mechanism of drug action Oncology (Williston Park) 2000 14 10 Suppl 9 13 18 11098484
   PubMed Web of Science ®Google Scholar
• Hong RL Sheen TS Ko JY Hsu MM Wang CC Ting LL Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study Br J Cancer 1999 80 12 1962 1967 10471046
   PubMed Web of Science ®Google Scholar
• Leong SS Wee J Rajan S Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma Cancer 2008 113 6 1332 1337 18615622
   PubMed Web of Science ®Google Scholar
• Lee AWM Ng WT Chan OSH Sze HCK If concurrent-adjuvant chemoradiotherapy is beneficial for locoregionally advanced nasopharyngeal carcinoma, would changing the sequence to induction-concurrent achieve better outcome? J Radiat Oncol 2012 1 2 107 115
   Google Scholar
• Lee AW Lau KY Hung WM Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma Radiother Oncol 2008 87 2 204 210 18329742
   PubMed Web of Science ®Google Scholar
• Rischin D Corry J Smith J Stewart J Hughes P Peters L Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation J Clin Oncol 2002 20 7 1845 1852 11919243
   PubMed Web of Science ®Google Scholar
• Hui EP Ma BB Chan AT Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma J Clin Oncol 2009 27 2 242 249 19064973
   PubMed Web of Science ®Google Scholar
• Fountzilas G Ciuleanu E Bobos M Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation Ann Oncol 2012 23 2 427 435 21525406
   PubMed Web of Science ®Google Scholar
• Huang PY Cao KJ Guo X A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma Oral Oncol 2012 48 10 1038 1044 22591726
   PubMed Web of Science ®Google Scholar
• Yeh SA Tang Y Lui CC Huang EY Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy Jpn J Clin Oncol 2006 36 3 132 136 16520357
   PubMed Web of Science ®Google Scholar
• Lin S Tham IW Pan J Han L Chen Q Lu JJ Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer Am J Clin Oncol 2012 35 5 474 479 21577086
   PubMed Web of Science ®Google Scholar
• Setton J Wolden S Caria N Lee N Definitive treatment of metastatic nasopharyngeal carcinoma: report of 5 cases with review of literature Head Neck 2012 34 5 753 757 22488786
   PubMed Web of Science ®Google Scholar
• Leung TW Tung SY Sze WK Sze WM Wong VY O SK Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 2000 47 2 405 412 10802367
   PubMed Web of Science ®Google Scholar
• Qiu S Lin S Tham IW Pan J Lu J Lu JJ Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 2012 83 2 676 683 22024207
   PubMed Web of Science ®Google Scholar
• Chua DT Wu SX Lee V Tsang J Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis Head Neck Oncol 2009 1 13 19463191
   PubMedGoogle Scholar
• Wei WI Chan JY Ng RW Ho WK Surgical salvage of persistent or recurrent nasopharyngeal carcinoma with maxillary swing approach – critical appraisal after 2 decades Head Neck 2011 33 7 969 975 20967865
   PubMed Web of Science ®Google Scholar
• Mai HQ Mo HY Deng JF Endoscopic microwave coagulation therapy for early recurrent T1 nasopharyngeal carcinoma Eur J Cancer 2009 45 7 1107 1110 19327985
   PubMed Web of Science ®Google Scholar
• Wei WI Kwong DL Recurrent nasopharyngeal carcinoma: surgical salvage vs additional chemoradiation Curr Opin Otolaryngol Head Neck Surg 2011 19 2 82 86 21412154
   PubMed Web of Science ®Google Scholar
• Chen MY Wen WP Guo X Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma Laryngoscope 2009 119 3 516 522 19235750
   PubMed Web of Science ®Google Scholar
• Ong YK Solares CA Lee S Snyderman CH Fernandez-Miranda J Gardner PA Endoscopic nasopharyngectomy and its role in managing locally recurrent nasopharyngeal carcinoma Otolaryngol Clin North Am 2011 44 5 1141 1154 21978898
   PubMed Web of Science ®Google Scholar
• Hua YJ Han F Lu LX Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy Eur J Cancer 2012 48 18 3422 3428 22835782
   PubMed Web of Science ®Google Scholar
• Wei WI Lam KH Ho CM Sham JS Lau SK Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma Am J Surg 1990 160 4 439 442 2221251
   PubMed Web of Science ®Google Scholar
• Zhang L Zhu YX Wang Y Huang CP Wu Y Ji QH Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience Ann Surg Oncol 2011 18 1 233 238 20737217
   PubMed Web of Science ®Google Scholar
• Khafif A Ferlito A Takes RP Thomas Robbins K Is it necessary to perform radical neck dissection as a salvage procedure for persistent or recurrent neck disease after chemoradiotherapy in patients with nasopharyngeal cancer? Eur Arch Otorhinolaryngol 2010 267 7 997 999 20352240
   PubMed Web of Science ®Google Scholar
• Lo WC Wang CP Ko JY Salvage treatment for isolated regional failure of nasopharyngeal carcinoma after primary radiotherapy Ann Surg Oncol 2012 19 3 1001 1008 21913020
   PubMed Web of Science ®Google Scholar
• Chua DT Nicholls JM Sham JS Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys 2004 62 1 11 20 15093894
   PubMed Web of Science ®Google Scholar
• Chan AT Hsu MM Goh BC Multicenter, phase III study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma J Clin Oncol 2005 23 15 3568 3576 15809453
   PubMed Web of Science ®Google Scholar
• Chua DT Wei WI Wong MP Sham JS Nicholls J Au GK Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma Head Neck 2008 30 7 863 867 18213730
   PubMed Web of Science ®Google Scholar
• Ma B Hui EP King A A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy Cancer Chemother Pharmacol 2008 62 1 59 64 17762933
   PubMed Web of Science ®Google Scholar
• Chen CY Zhao C Gao L An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): a 2-year follow-up report. 2012 ASCO Annal Meeting J Clin Oncol 2012 30 Suppl 5535
   Google Scholar
• Guang-Wu H Sunagawa M Jie-En L The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma Laryngoscope 2000 110 12 2066 2069 11129022
   PubMed Web of Science ®Google Scholar
• Wakisaka N Wen QH Yoshizaki T Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma Laryngoscope 1999 109 5 810 814 10334236
   PubMed Web of Science ®Google Scholar
• Hui EP Ma BB King AD Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation Ann Oncol 2011 22 6 1280 1287 21317222
   PubMed Web of Science ®Google Scholar
• Thompson MP Kurzrock R Epstein-Barr virus and cancer Clin Cancer Res 2004 10 3 803 821 14871955
   PubMed Web of Science ®Google Scholar
• Masmoudi A Toumi N Khanfir A Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma Cancer Treat Rev 2007 33 6 499 505 17544585
   PubMed Web of Science ®Google Scholar
• Merlo A Turrini R Dolcetti R Zanovello P Rosato A Immunotherapy for EBV-associated malignancies Int J Hematol 2011 93 3 281 293 21336546
   PubMed Web of Science ®Google Scholar
• Chua D Huang J Zheng B Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma Int J Cancer 2001 94 1 73 80 11668481
   PubMed Web of Science ®Google Scholar
• Comoli P Pedrazzoli P Maccario R Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes J Clin Oncol 2005 23 35 8942 8949 16204009
   PubMed Web of Science ®Google Scholar
• Straathof KC Bollard CM Popat U Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes Blood 2005 105 5 1898 1904 15542583
   PubMed Web of Science ®Google Scholar
• Louis CU Straathof K Bollard CM Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma J Immunother 2010 33 9 983 990 20948438
   PubMed Web of Science ®Google Scholar
• Brooks L Yao QY Rickinson AB Young LS Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts J Virol 1992 66 5 2689 2697 1313894
   PubMed Web of Science ®Google Scholar
• Young LS Dawson CW Clark D Epstein-Barr virus gene expression in nasopharyngeal carcinoma J Gen Virol 1988 69 Pt 5 1051 1065 2836550
   PubMed Web of Science ®Google Scholar
• Chia WK Wang WW Teo M A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1–LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma Ann Oncol 2012 23 4 997 1005 21821548
   PubMed Web of Science ®Google Scholar
• Comoli P De Palma R Siena S Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma Ann Oncol 2004 15 1 113 117 14679129
   PubMed Web of Science ®Google Scholar
• Taylor GS Haigh TA Gudgeon NH Dual stimulation of Epstein-Barr virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma J Virol 2004 78 2 768 778 14694109
   PubMed Web of Science ®Google Scholar
• Duraiswamy J Sherritt M Thomson S Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma Blood 2003 101 8 3150 3156 12468425
   PubMed Web of Science ®Google Scholar
• Duraiswamy J Bharadwaj M Tellam J Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine Cancer Res 2004 64 4 1483 1489 14973049
   PubMed Web of Science ®Google Scholar
• Bollard CM Straathof KC Huls MH The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease J Immunother 2004 27 4 317 327 15235393
   PubMed Web of Science ®Google Scholar
• Smith C Tsang J Beagley L Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy Cancer Res 2012 72 5 1116 1125 22282657
   PubMed Web of Science ®Google Scholar
• Taheri-Kadkhoda Z Björk-Eriksson T Nill S Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons Radiat Oncol 2008 3 4 18218078
   PubMed Web of Science ®Google Scholar
• Widesott L Pierelli A Fiorino C Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation Int J Radiat Oncol Biol Phys 2008 72 2 589 596 18793962
   PubMed Web of Science ®Google Scholar